Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859401 · ClinicalTrials.gov registry record · NA
Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas
A NA study, sponsored by Marc Breton.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03859401 is a NA study that has completed, run by Marc Breton. The registered enrollment target is 15 participants.
The verdict
NCT03859401, a NA study, has completed, sponsored by Marc Breton.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This is a randomized crossover trial with 1:1 randomization to the admission sequence of using the Control AP system (rMPC - Naïve Model Predictive Control) vs. Experimental AP system (EnMPC - Ensemble Model Predictive Control) over approximately 4 months. Eligible participants will proceed to the Data Collection Phase for approximately 28 days, during which they will participate in regimented exercise activities. If the participant collected adequate data during the Data Collection Phase, they will be randomized and undergo the study admissions in the assigned sequence. Each admission is approximately 36 hours in length and will consist of one afternoon of exercise and one without.
Interventions
- DEVICE EnMPC (Ensemble Model Predictive Control) AP Controller
- DEVICE rMPC (Naïve Model Predictive Control) AP Controller
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-04-12 |
| Est. Completion | 2020-01-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03859401
The ClinicalTrials.gov registry entry for NCT03859401 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marc Breton, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EnMPC (Ensemble Model Predictive Control) AP Controller is the first listed.
NCT03859401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03859401 about?
NCT03859401 is a clinical study titled "Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas". This is a randomized crossover trial with 1:1 randomization to the admission sequence of using the Control AP system (rMPC - Naïve Model Predictive Control) vs. Experimental AP system (EnMPC - Ensemble Model Predictive Control) over approximately 4 months. Eligible participants will proceed to the D...
What is the current status of trial NCT03859401?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2019-04-12. Estimated completion is 2020-01-13.
What interventions are being tested in trial NCT03859401?
The interventions under investigation include: EnMPC (Ensemble Model Predictive Control) AP Controller (DEVICE), rMPC (Naïve Model Predictive Control) AP Controller (DEVICE).
Who is sponsoring clinical trial NCT03859401?
This trial is sponsored by Marc Breton, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.